LONDON, May 28, 2012 /PRNewswire/ -- THIS RELEASE IS INTENDED EXCLUSIVELY FOR EUROPEAN MEDIA Data presented today from the VOYAGER study demonstrate the benefits

PARIS and TARRYTOWN, New York, May 26, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc.

IRVINE, Calif., May 24, 2012 /PRNewswire/ -- Aviir, a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory

Statins prevent cancer and reduce death from all causes in heart transplant recipients.

Cancer is the leading cause of death late after heart transplantation. Now, new research shows that statins, immunomondulatory drugs, may benefit patients beyond their lipid lowering effects.